Clinical Trial Update: Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

View source ↗

Summary

A pilot study investigating the ReBuilder to treat chemotherapy-induced peripheral neuropathy in breast cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathy

Drugs mentioned

• ReBuilder

Snippet

Sponsor: Eastern Regional Medical Center | Conditions: Peripheral Neuropathy | Status: WITHDRAWN